LUNR:NASDAQIntuitive Machines, Inc. Analysis
Data as of 2026-09-05 - not real-time
$14.81
Latest Price
9/10Risk
Risk Level: High
Executive Summary
Intuitive Machines, Inc. is priced at $14.81, and its moving averages give no clean directional read — the structure is neutral. Over a rolling month the price has gained 14.6%. With RSI at 40.9 the momentum picture is neutral, alongside a bearish MACD signal. The recent range runs from support at $14.18 up to resistance at $20.84.
The company is not currently profitable on a trailing basis, so earnings multiples offer no valuation support. The average analyst target implies 99.2% above today's level. Revenue is growing at 309.8% on a -26.6% profit margin.
Risk comes out at 9 of a possible 10, a high reading. With 30-day volatility of 81.2%, a beta of 3.55 and a maximum drawdown of 75.1%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 95 on the fear-greed composite.
All three time horizons resolve to hold, carrying 1/10 conviction.
The company is not currently profitable on a trailing basis, so earnings multiples offer no valuation support. The average analyst target implies 99.2% above today's level. Revenue is growing at 309.8% on a -26.6% profit margin.
Risk comes out at 9 of a possible 10, a high reading. With 30-day volatility of 81.2%, a beta of 3.55 and a maximum drawdown of 75.1%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 95 on the fear-greed composite.
All three time horizons resolve to hold, carrying 1/10 conviction.
Top Market Events
Intuitive Machines Inc LUNR posts a 4x revenue increase to $206 million and secures a record $1.A new European defense contract and a fresh analyst Buy rating landed for Planet Labs on Thursday, yet the stock...Contract expands the IM 300 customer base and reflects growing demand for rapidly produced, mission-configurable...
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 2/10
Key Factors
- Trading below the 200-day average of 19.78
- MACD momentum is negative
- 30-day price change of +14.6%
Medium Term
1–3 yearsNeutral
Model confidence: 1/10
Key Factors
- Trading below the 200-day average of 19.78
- Analyst targets imply +99.2% versus the current price
- 30-day volatility of 81.2%
Long Term
> 3 yearsNeutral
Model confidence: 1/10
Key Factors
- Negative profit margin of -26.6%
- Analyst targets imply +99.2% versus the current price
- Negative return on equity of -30.8%
Key Metrics & Analysis
Financial Health
Revenue Growth309.80%
Profit Margin-26.64%
P/E Ratio-95.5
ROE-30.77%
ROA-5.52%
Debt/Equity52.82
P/B Ratio-8.6
Op. Cash Flow$-126352000
Free Cash Flow$-79995872
Industry P/E28.5
Technical Analysis
TrendNeutral
RSI40.9
Support$14.18
Resistance$20.84
MA 20$16.78
MA 50$15.99
MA 200$19.78
MACDBearish
VolumeDecreasing
Fear & Greed Index95.48
Valuation
Target Price$29.50
Upside/Downside99.19%
GradeFair
TypeGrowth
Risk Assessment
Beta3.55
Volatility81.18%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.